APPROVALS

U.S. FDA approves Pfizer’s BEQVEZ for adults with hemophilia B

The U.S. Food and Drug Administration (FDA) has approved Pfizer's BEQVEZ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX...

View the Online Magazine

Latest Issue

Magazine Archive

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Approvals

Manufacturiung

Finance

Research & Development
Latest

R&D

AskBio receives FDA Fast Track Designation for investigational gene therapy program in congestive heart failure

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has been...
R&D

Genomics plc and GSK establish precision medicine collaboration

Genomics plc and GSK have established a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve...
R&D

After record low global pharma companies’ return on R&D investment increases

The world’s top 20 pharmaceutical companies collectively spent $145 billion on their research and development (R&D) investments in 2022-23, up from $139 billion in...
R&D

Merck invests over €300m in new life science research center in Germany

Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the...
R&D

New research centre to improve tests and treatments for rare lung diseases

A £9.4 million collaborative research centre will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases. The LifeArc...

Appointments

© 2021 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks